Over $1bn raised in venture capital funding for gene editing in 2021
Gene editing is being explored in a wide range of diseases, including single-gene rare disorders such as sickle cell disease…
By
Gene editing is being explored in a wide range of diseases, including single-gene rare disorders such as sickle cell disease…
ByCalifornia-based Retrotope aims to expand its investor pool as it prepares to potentially go public in the coming years.
ByCompanies have reason to be sceptical about investing in Asia in general and in China in particular. But Asia investment…
Thank you for subscribing to Pharmaceutical Technology